stockrow
Friday 6 November 2026
Export CBT’s income statement to Excel — free account
Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
71.14
1.83
−2.51%
Follow CBT
Alert me
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
22.21 | 15.06 | 0.00 | 17.23 | 0.00 | 11.55 | 17.75 | 8.78 | 16.58 | 12.55 |
Piotroski F-Score |
— | 8 | 4 | 7 | 3 | 7 | 5 | 8 | 7 | 6 |
Altman Z-Score |
3.21 | 3.28 | 3.10 | 3.17 | 2.28 | 2.85 | 3.21 | 3.51 | 4.25 | 3.53 |
P/S ratio |
1.36 | 1.32 | 1.19 | 0.80 | 0.78 | 0.83 | 0.84 | 0.97 | 1.54 | 1.10 |
Altman Z″-Score (non-manufacturers) |
4.48 | 4.44 | 3.28 | 4.11 | 2.70 | 3.13 | 3.69 | 4.54 | 4.86 | 4.51 |
P/FCF ratio |
11.05 | 17.79 | 35.85 | 19.14 | 11.52 | 45.84 | 0.00 | 10.66 | 13.66 | 10.44 |
P/Operating CF |
33.72 | 22.77 | 24.98 | 13.50 | 20.60 | 28.42 | 34.38 | 27.66 | 30.19 | 18.65 |
Beneish M-Score |
(2.72) | (2.43) | (3.02) | (2.81) | (3.64) | (2.09) | (2.01) | (2.65) | (2.81) | (2.94) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 85 |
P/B ratio |
2.38 | 2.20 | 3.03 | 2.35 | 2.51 | 2.61 | 3.50 | 2.71 | 3.87 | 2.40 |
Price to Tangible BV |
3.03 | 2.68 | 3.56 | 2.81 | 3.53 | 3.34 | 4.30 | 3.15 | 4.39 | 2.69 |
EV/Sales |
1.65 | 1.55 | 1.45 | 1.07 | 1.15 | 1.13 | 1.12 | 1.24 | 1.77 | 1.33 |
EV/EBITDA |
9.77 | 8.56 | 12.21 | 7.83 | 16.78 | 6.25 | 9.06 | 7.25 | 9.25 | 6.39 |
EV/Operating CF |
10.17 | 12.12 | 15.77 | 9.79 | 7.97 | 14.93 | 48.47 | 8.16 | 10.22 | 7.45 |
EV/FCF |
13.46 | 20.99 | 43.52 | 25.58 | 16.97 | 61.87 | (52.12) | 13.56 | 15.69 | 12.67 |
Quick Ratio |
1.65 | 1.09 | 0.85 | 1.17 | 1.08 | 0.71 | 0.94 | 1.14 | 1.24 | 0.97 |
Current Ratio |
2.64 | 1.75 | 1.46 | 2.02 | 1.85 | 1.24 | 1.65 | 1.98 | 2.08 | 1.61 |
Net Debt/EBITDA |
1.75 | 1.31 | 2.15 | 1.97 | 5.39 | 1.62 | 2.31 | 1.55 | 1.20 | 1.13 |
Debt/Assets |
30.15% | 27.68% | 30.92% | 35.42% | 40.09% | 35.15% | 40.94% | 35.41% | 30.51% | 29.62% |
Debt/Equity |
0.67 | 0.57 | 0.78 | 0.94 | 1.37 | 1.07 | 1.40 | 0.91 | 0.72 | 0.66 |
Asset Turnover |
0.79 | 0.85 | 0.99 | 1.07 | 0.90 | 1.12 | 1.27 | 1.10 | 1.09 | 0.98 |
Operating CF/Net income |
2.68 | 1.40 | (2.61) | 2.31 | (1.58) | 1.03 | 0.48 | 1.34 | 1.82 | 2.01 |
Capex/Depreciation |
(0.60) | (0.95) | (0.79) | (1.51) | (1.27) | (1.22) | (1.32) | (1.65) | (1.60) | (1.78) |
Interest Coverage |
4.57 | 6.38 | 2.67 | 5.19 | 0.40 | 9.27 | 6.95 | 5.84 | 7.58 | 8.17 |
| 10.77% | 16.55% | (7.85%) | 13.01% | (24.44%) | 26.26% | 19.70% | 36.49% | 25.36% | 20.09% | |
| 4.78% | 7.78% | (3.46%) | 5.03% | (8.23%) | 8.21% | 6.12% | 12.48% | 10.35% | 8.77% | |
ROIC |
7.40% | 9.31% | 4.27% | 9.43% | 0.74% | 13.62% | 10.72% | 13.45% | 15.31% | 15.06% |
Return on Tangible Assets |
7.53% | 13.32% | (6.59%) | 8.01% | (13.50%) | 15.11% | 10.53% | 20.08% | 16.05% | 14.44% |
Average Days of Receivables |
69.03 | 70.80 | 71.72 | 57.97 | 58.37 | 69.06 | 70.62 | 64.53 | 66.99 | 65.96 |
Research and Development Expense of Revenue |
2.20% | 2.10% | 2.04% | 1.80% | 2.18% | 1.64% | 1.27% | 1.45% | 1.58% | 1.59% |
Selling, General and Administrative Expense of Revenue |
11.41% | 9.64% | 9.50% | 8.69% | 11.17% | 8.48% | 5.97% | 6.44% | 7.09% | 7.00% |
Intangible Assets out of Total Assets |
0.10 | 0.09 | 0.06 | 0.06 | 0.09 | 0.07 | 0.05 | 0.05 | 0.05 | 0.05 |
Share Based Compensation of Revenue |
0.71% | 0.59% | 0.68% | 0.33% | 0.34% | 0.62% | 0.53% | 0.51% | 0.63% | 0.65% |
Graham Net Nets |
(0.19) | (0.12) | (0.15) | (0.25) | (0.48) | (0.28) | (0.19) | (0.15) | (0.09) | (0.14) |
Graham Number |
34.17 | 47.29 | 0.00 | 33.81 | 0.00 | 43.33 | 38.46 | 66.13 | 66.15 | 65.80 |
Earnings Yield |
4.50% | 6.64% | (2.98%) | 5.80% | (11.77%) | 8.66% | 5.63% | 11.39% | 6.03% | 7.97% |
Free Cash Flow Yield |
9.05% | 5.62% | 2.79% | 5.23% | 8.68% | 2.18% | (2.58%) | 9.38% | 7.32% | 9.57% |
Revenue per Share |
38.64 | 43.61 | 52.54 | 56.85 | 46.18 | 60.12 | 76.48 | 70.07 | 72.49 | 69.14 |
Operating CF per Share |
6.28 | 5.59 | 4.83 | 6.18 | 6.66 | 4.53 | 1.77 | 10.61 | 12.56 | 12.38 |
Capex per Share |
(1.54) | (2.36) | (3.08) | (3.82) | (3.53) | (3.44) | (3.42) | (4.22) | (4.37) | (5.10) |
Free Cash Flow per Share |
4.74 | 3.23 | 1.75 | 2.37 | 3.13 | 1.09 | (1.65) | 6.38 | 8.19 | 7.28 |
Cash per Share |
3.21 | 4.49 | 2.84 | 2.88 | 2.67 | 2.96 | 3.65 | 4.24 | 4.05 | 4.80 |
Shareholders Equity per Share |
21.99 | 26.08 | 20.73 | 19.32 | 14.38 | 19.22 | 18.27 | 25.08 | 28.86 | 31.75 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
21.99 | 26.08 | 20.73 | 19.32 | 14.38 | 19.22 | 18.27 | 25.08 | 28.86 | 31.75 |
Free Cash Flow |
296.00 | 201.00 | 108.00 | 139.00 | 177.00 | 62.00 | (93.00) | 358.00 | 451.00 | 391.00 |
Working Capital |
650.00 | 557.00 | 434.00 | 611.00 | 449.00 | 278.00 | 715.00 | 804.00 | 833.00 | 582.00 |
Capital Expenditures |
(96.00) | (147.00) | (190.00) | (224.00) | (200.00) | (195.00) | (193.00) | (237.00) | (241.00) | (274.00) |
Net Current Asset Value |
(616.00) | (414.00) | (579.00) | (660.00) | (989.00) | (791.00) | (673.00) | (571.00) | (541.00) | (571.00) |
EV/EBIT |
16.14 | 12.48 | 32.64 | 11.62 | 143.01 | 8.45 | 12.46 | 9.23 | 11.52 | 7.98 |
Capex to Sales |
0.04 | 0.05 | 0.06 | 0.07 | 0.08 | 0.06 | 0.04 | 0.06 | 0.06 | 0.07 |
Price to Operating Income |
13.24 | 10.58 | 26.89 | 8.69 | 97.11 | 6.26 | 9.28 | 7.26 | 10.03 | 6.58 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.12 | 0.19 | 0.11 | 0.12 | 0.12 | 0.12 | 0.10 | 0.10 | 0.09 |
Cash ROIC |
11.90% | 7.10% | 4.40% | 5.87% | 8.51% | 2.56% | (3.47%) | 12.26% | 15.27% | 12.64% |
Accounts Receivable Turnover |
5.17 | 5.53 | 5.57 | 5.72 | 5.51 | 6.41 | 5.84 | 5.14 | 5.59 | 5.29 |
Accounts Payable Turnover |
4.88 | 5.02 | 4.62 | 4.61 | 4.12 | 4.52 | 5.00 | 4.73 | 4.76 | 4.19 |
Inventory Turnover |
4.97 | 5.32 | 5.23 | 5.43 | 5.12 | 5.92 | 5.79 | 4.95 | 5.34 | 5.25 |
Average Days of Payables |
72.36 | 80.97 | 90.59 | 73.91 | 84.26 | 93.28 | 75.10 | 70.83 | 81.33 | 85.29 |
Days of Inventory on Hand |
67.99 | 76.72 | 75.51 | 64.14 | 61.98 | 73.14 | 70.54 | 69.06 | 66.41 | 66.34 |
Average Receivables |
466.50 | 491.50 | 582.00 | 583.50 | 474.00 | 531.50 | 740.50 | 765.50 | 714.00 | 702.00 |
Average Payables |
376.50 | 410.50 | 535.00 | 575.00 | 512.50 | 577.50 | 687.00 | 653.50 | 638.00 | 662.00 |
Average Inventory |
369.50 | 387.50 | 472.00 | 488.50 | 412.50 | 441.00 | 593.50 | 624.50 | 568.50 | 528.00 |
Average Assets |
3,055.00 | 3,186.50 | 3,291.00 | 3,124.00 | 2,892.50 | 3,043.50 | 3,415.50 | 3,564.50 | 3,670.00 | 3,775.50 |
Average Common Equity |
1,355.00 | 1,498.50 | 1,452.00 | 1,206.50 | 974.00 | 952.00 | 1,061.00 | 1,219.50 | 1,498.50 | 1,647.50 |
Columns are period end dates · fundamentals updated 5 Nov 2026